与心脏性休克死亡率相关的预后因素 - 一个系统性审查和元分析
Richard G Jung1,2,3,4, Cameron Stotts1,5, Arnav Gupta1,5
1Division of Cardiology, University of Ottawa Heart Institute.
NEJM evidence
|October 22, 2024
概括
心脏性休克的死亡率很高. 高龄,病和心脏骤停增加风险,而再血管可能会降低这些患者的死亡率.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 研究成果 研究成果 研究成果
背景情况:
- 心脏性休克与高的早期死亡率有关,通常超过50%.
- 确定预后因素对于改善患者的治疗结果至关重要.
研究的目的:
- 系统地审查和元分析与心脏病性休克的住院和30天死亡率相关的预后因素.
- 确定影响心脏性休克结果的可修改和不可修改因素.
主要方法:
- 系统审查和对2023年6月5日之前发表的研究进行元分析.
- 纳入标准:关于预后因素和心脏性休克死亡率的研究 (不包括儿科,死后,<100名患者).
主要成果:
- 分析了160项涉及2,459,703名患者的研究;住院死亡率中位数为41.4%.
- 增加死亡风险因素:年龄≥75,外围动脉疾病,慢性病,女性性别,非医院心脏骤停,左主动脉疾病,LVEF<30%,透析,机械循环支持.
- 降低死亡率的关联:冠状动脉旁路移植,穿皮冠状动脉干预.
结论:
- 患者,表现和治疗因素之间的量化关联以及心脏病性休克的早期死亡率.
- 对预后因素的更好理解可以改善临床风险评估,风险工具开发和临床试验分析.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure I: Introduction
1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Cardiopulmonary Resuscitation IV: Pharmacological Management
1
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K


